XML 31 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Statement [Abstract]        
Development revenue $ 230 $ 660 $ 1,691 $ 1,840
Product revenue 16 176 44 2,312
Contract revenue 722 128 1,063 483
Total revenue 968 964 2,798 4,635
Cost of product revenue 5 8 28 1,509
Cost of contract revenue 363 76 507 239
Total cost of revenue 368 84 535 1,748
Gross margin 600 880 2,263 2,887
Research and development expense 2,369 2,893 7,148 7,484
Sales, marketing, general and administrative expense 1,588 2,132 5,416 6,636
Gain on disposal of fixed assets (1) (33) (29) (35)
Gain on sale of previously reserved inventory    (26) (455) (32)
Total operating expenses 3,956 4,966 12,080 14,053
Loss from operations (3,356) (4,086) (9,817) (11,166)
Change in warrant liability 0 397 0 397
Loss on warrant exchange 0 18 (4,967) 18
Other income (expense) 1 4 10 (6)
Net loss $ (3,355) $ (3,667) $ (14,774) $ (10,757)
Net loss per share - basic and diluted $ (0.08) $ (0.13) $ (0.36) $ (0.40)
Weighted-average shares outstanding - basic and diluted 43,858 28,448 40,605 26,739